Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
- PMID: 15168158
- PMCID: PMC7102000
- DOI: 10.1007/s10067-004-0864-0
Recurrent life-threatening thromboembolism and catastrophic antiphospholipid syndrome in a patient despite sufficient oral anticoagulation
Abstract
We report on a 32-year old female patient with primary antiphospholipid syndrome (PAPS) and several thromboembolic events despite stable doses of oral anticoagulation, good patient compliance and maintained INR values of >3. Over the preceding 3 years the patient had presented a wide spectrum of manifestations of APS, including recurrent venous and arterial thromboses, cardiac, gynecological (HELLP syndrome), neurological involvements, livedo reticularis, a mild thrombocytopenia and the most feared manifestation of the catastrophic antiphospholipid syndrome (CAPS). Life-threatening bilateral subdural bleeding occurred while she was anticoagulated. The clinical features appeared to be refractory to oral anticoagulation with phenprocoumon. They were life threatening on each occasion and she developed repetitive episodes of organ damage with cardiac insufficiency (NYHA III), pulmonary hypertension and other residual defects. Even during heparinization recurrent thromboembolism supervened as well as livedo reticularis of the extremities. Lupus anticoagulants (LAC), anticardiolipin (aCL) antibodies and anti-beta(2)-glycoprotein-1 (beta(2)GPI) titers were all markedly elevated. This case report shows that recurrent episodes of thrombosis can occur despite seemingly adequate anticoagulation in patients with CAPS.
Figures
Similar articles
-
Characteristics and quality of oral anticoagulation treatment in pediatric patients in the Netherlands based on the CAPS cohort.J Thromb Haemost. 2018 Jan;16(1):116-124. doi: 10.1111/jth.13897. Epub 2017 Nov 23. J Thromb Haemost. 2018. PMID: 29108090
-
Combined plasmapheresis and immunosuppression as rescue treatment of a patient with catastrophic antiphospholipid syndrome occurring despite anticoagulation: a case report.Blood Coagul Fibrinolysis. 2003 Jun;14(4):395-9. doi: 10.1097/00001721-200306000-00011. Blood Coagul Fibrinolysis. 2003. PMID: 12945882
-
Bleeding and recurrent thrombosis in definite antiphospholipid syndrome: analysis of a series of 66 patients treated with oral anticoagulation to a target international normalized ratio of 3.5.Arch Intern Med. 2002 May 27;162(10):1164-9. doi: 10.1001/archinte.162.10.1164. Arch Intern Med. 2002. PMID: 12020188
-
Clinical and therapeutic aspects associated to phospholipid binding antibodies (lupus anticoagulant and anticardiolipin antibodies).Haemostasis. 1994 May-Jun;24(3):165-74. doi: 10.1159/000217098. Haemostasis. 1994. PMID: 7988946 Review.
-
Antiphospholipid syndrome.Dis Mon. 2003 Dec;49(12):696-741. doi: 10.1016/j.disamonth.2003.10.001. Dis Mon. 2003. PMID: 14679358 Review.
Cited by
-
[The catastrophic antiphospholipid antibody syndrome: case report and review of the literature].Nervenarzt. 2015 Feb;86(2):205-9. doi: 10.1007/s00115-015-4263-3. Nervenarzt. 2015. PMID: 25637082 Review. German. No abstract available.
-
Perioperative management of patients with antiphospholipid and catastrophic antiphospholipid syndrome undergoing urgent neurosurgery.Front Pharmacol. 2023 Sep 1;14:1253655. doi: 10.3389/fphar.2023.1253655. eCollection 2023. Front Pharmacol. 2023. PMID: 37719849 Free PMC article. No abstract available.
-
[Primary antiphospholipid syndrome: newly developed leg ulcer and history of stroke].Hautarzt. 2013 Sep;64(9):666-70. doi: 10.1007/s00105-013-2601-6. Hautarzt. 2013. PMID: 23744031 German.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous